# Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients

> **NCT01789619** · — · COMPLETED · sponsor: **UMC Utrecht** · enrollment: 9 (actual)

## Conditions studied

- Atopic Dermatitis

## Interventions

- **DRUG:** Extended release tacrolimus (Advagraf®)

## Key facts

- **NCT ID:** NCT01789619
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-10
- **Primary completion:** 2014-01
- **Final completion:** 2014-01
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2015-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01789619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01789619, "Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01789619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*